Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Austin Dulak
Affiliation
ORCID
Career Start Year
2008
Papers
19
H Index
17
Expertise
CM4AI Collaborator
PMID
Paper Title
Journal Title
Published Year
37219538
SRF617 Is a Potent Inhibitor of CD39 with Immunomodulatory and Antitumor Properties.
2023
29808010
Targeting wild-type KRAS-amplified gastroesophageal cancer through combined MEK and SHP2 inhibition.
Nat Med
2018
30093730
Author Correction: Targeting wild-type KRAS-amplified gastroesophageal cancer through combined MEK and SHP2 inhibition.
Nat Med
2018
30036377
BRD4 amplification facilitates an oncogenic gene expression program in high-grade serous ovarian cancer and confers sensitivity to BET inhibitors.
PLoS One
2018
29636547
BRD4 facilitates replication stress-induced DNA damage response.
Oncogene
2018
28073847
Identification of CCR2 and CD180 as Robust Pharmacodynamic Tumor and Blood Biomarkers for Clinical Use with BRD4/BET Inhibitors.
Clin Cancer Res
2017
29245897
Comparative analysis of primary <i>versus</i> relapse/refractory DLBCL identifies shifts in mutation spectrum.
Oncotarget
2017
27775716
Potent and selective bivalent inhibitors of BET bromodomains.
Nat Chem Biol
2016
26781748
Multi-omic measurement of mutually exclusive loss-of-function enriches for candidate synthetic lethal gene pairs.
BMC Genomics
2016
27573426
AZD5153: A Novel Bivalent BET Bromodomain Inhibitor Highly Active against Hematologic Malignancies.
Mol Cancer Ther
2016
24509200
Comparison of cancer-associated genetic abnormalities in columnar-lined esophagus tissues with and without goblet cells.
Annals of Surgery
2014
24296828
Acquired resistance to dasatinib in lung cancer cell lines conferred by DDR2 gatekeeper mutation and NF1 loss.
Mol Cancer Ther
2014
23525077
Exome and whole-genome sequencing of esophageal adenocarcinoma identifies recurrent driver events and mutational complexity.
Nat Genet
2013
23770567
Mutational heterogeneity in cancer and the search for new cancer-associated genes.
Nature
2013
22751462
Gastrointestinal adenocarcinomas of the esophagus, stomach, and colon exhibit distinct patterns of genome instability and oncogenesis.
Cancer Res
2012
22400064
Optical Imaging with a Cathepsin B Activated Probe for the Enhanced Detection of Esophageal Adenocarcinoma by Dual Channel Fluorescent Upper GI Endoscopy.
Theranostics
2012
21423210
HGF-independent potentiation of EGFR action by c-Met.
Oncogene
2011
19826040
microRNA-21 negatively regulates Cdc25A and cell cycle progression in colon cancer cells.
Cancer Research
2009
18645002
Therapeutic targeting of human hepatocyte growth factor with a single neutralizing monoclonal antibody reduces lung tumorigenesis.
Molecular Cancer Therapeutics
2008
1 - 19 of 19
Column Actions
Search
Recommended Authors
Collaborators
Adam J Bass
Co-authored papers
8
Michael Zinda
Repare Therapeutics Inc.
Co-authored papers
4
Steven E Schumacher
Co-authored papers
4
Rameen Beroukhim
Co-authored papers
4
Stephen Fawell
Oncology R&D
Co-authored papers
4
Matthew Meyerson
Broad Institute
Co-authored papers
3
Jonathan R Dry
Present Address: Tempus Labs Inc.
Co-authored papers
3
Gordon Saksena
Broad Institute of Massachusetts Institute of Technology and Harvard
Co-authored papers
3
Alex H Ramos
Co-authored papers
3
Gordon B Mills
Knight Cancer Institute, Oregon Health and Sciences University
Co-authored papers
3
Petar Stojanov
Co-authored papers
2
Carrie Sougnez
The Broad Institute of Harvard and MIT
Co-authored papers
2
John Alan Diehl
Case Western Reserve University School of Medicine
Co-authored papers
2
Eric S Lander
Vanderbilt-Ingram Cancer Center, Vanderbilt University
Co-authored papers
2
Michael S Lawrence
Co-authored papers
2
Erica Shefler
Co-authored papers
2
Aaron McKenna
Co-authored papers
2
Christopher Szeto
La Trobe Institute for Molecular Science, La Trobe University
Co-authored papers
2
Douglas Voet
Co-authored papers
2
Todd R Golub
Broad Institute of MIT and Harvard
Co-authored papers
2
Andrey Sivachenko
Cystic Fibrosis Foundation
Co-authored papers
2
Peter S Hammerman
Novartis Institutes for BioMedical Research
Co-authored papers
2
Philipp Mertins
Co-authored papers
2
Chip Stewart
Broad Institute of MIT and Harvard
Co-authored papers
2
Stacey Gabriel
Broad Institute of MIT and Harvard
Co-authored papers
2
Kristian Cibulskis
Co-authored papers
2
Steven A Carr
Broad Institute of MIT and Harvard
Co-authored papers
2
Gad Getz
Broad Institute of the Massachusetts Institute of Technology and Harvard
Co-authored papers
2
Scott L Carter
Co-authored papers
2
Robert C Onofrio
The Broad Institute of Harvard and MIT
Co-authored papers
2
1 - 30